Literature DB >> 34146625

Duration of carbapenemase-producing Enterobacteriales carriage among ICU patients in Miami, FL: A retrospective cohort study.

Adriana Jimenez1, Kristopher Fennie2, L Silvia Munoz-Price3, Boubakari Ibrahimou4, Vukosava Pekovic5, Lilian M Abbo6, Octavio Martinez7, Gemma Rosello8, Kathleen Sposato8, Yohei Doi9, Mary Jo Trepka5.   

Abstract

BACKGROUND: Current recommendations by the Centers for Disease Control and Prevention suggest placing patients with carbapenem-producing Enterobacteriales (CPE) in contact precautions, but there is no consensus on the appropriate duration of precautions. AIM: We aimed to evaluate predictors for prolonged CPE carriage and median clearance time.
METHODS: Patients with first isolated CPE identified from 2012-2016 were followed for clearance of CPE using at least two rectal or tracheal aspirate surveillance cultures and clinical cultures during intensive-care-unit admission. Predictors associated with prolonged CPE carriage were assessed using Cox proportional-hazards.
RESULTS: Out of 75 eligible patients, 25 (33%) cleared their CPE-carrier status; median time to clearance was 80 days (Range, 16-457). Patients who were immunocompromised, had mechanical ventilation exposure, or exposure to carbapenems had 66%, 66%, and 86% (HR, 0.34, 0.34, and 0.14, respectively [P-value <.05]) lower probability of clearing compared to those immunocompetent of without such exposures. Patients with CPE isolated from more than one body site had a 5.3 times higher probability of clearing their CPE-carrier status (P-value <.001).
CONCLUSIONS: Patients immunocompromised, with mechanical ventilation exposure, or exposure to carbapenems had higher risk for prolonged CPE carriage. Infection prevention programs should consider these predictors as part of their assessment of discontinuing contact precautions among CPE carriers to prevent horizontal transmission and outbreaks within healthcare facilities.
Copyright © 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial stewardship; Carbapenemase; Carrier state; Enterobacteriaceae; Infection control; Patient isolation

Year:  2021        PMID: 34146625     DOI: 10.1016/j.ajic.2021.06.006

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  2 in total

1.  Carbapenem-Resistant Gram-Negative Bacteria-Related Healthcare-Associated Ventriculitis and Meningitis: Antimicrobial Resistance of the Pathogens, Treatment, and Outcome.

Authors:  Yi Ye; Yueyue Kong; Jiawei Ma; Guangzhi Shi
Journal:  Microbiol Spectr       Date:  2022-04-25

2.  Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.

Authors:  Lidia Kardaś-Słoma; Sandra Fournier; Jean-Claude Dupont; Lise Rochaix; Gabriel Birgand; Jean-Ralph Zahar; François-Xavier Lescure; Solen Kernéis; Isabelle Durand-Zaleski; Jean-Christophe Lucet
Journal:  Antimicrob Resist Infect Control       Date:  2022-09-19       Impact factor: 6.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.